Manipal Health Enterprises Ltd vs Mankind Pharma Ltd

A side-by-side comparison of Manipal Health Enterprises Ltd (MANIPALHOS) and Mankind Pharma Ltd (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Mankind Pharma Ltd leads MANIPALHOS vs MANKIND on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability22
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

MANKIND takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

55.86
P/E ratio
51.42
6.39
P/B ratio
6.30
0.00%
Dividend yield
0.04%
₹13.89
EPS
₹46.34

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

11.80%
Return on equity
13.10%
12.00%
Return on capital
14.00%
27.00%
EBITDA margin
25.00%
17.24%
Net margin
13.57%

Growth

MANIPALHOS takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

63.48%
Revenue CAGR (3Y)
17.73%
67.79%
Profit CAGR (3Y)
13.94%

Size & financial health

MANKIND takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.05L Cr
Market cap
₹99,602 Cr
₹3,104 Cr
Revenue
₹14,278 Cr
₹535 Cr
Net profit
₹1,938 Cr
1.35
Debt / equity
0.34
Manipal Health Enterprises Ltd
  • + ["Company has delivered good profit growth of 26.0% CAGR over last 5 years"]
  • ["Company has a low return on equity of 10.2% over last 3 years."]
Mankind Pharma Ltd
  • + ["Company has reduced debt."]
  • ["Promoter holding has decreased over last 3 years: -3.87%"]
Manipal Health Enterprises Ltd full analysis Mankind Pharma Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.